Rare diseases
Investigational molecules
Locations
Back to Italy677 clinical trials in Turin, Italy across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Pembrolizumab for Patients with Resectable Metastases from Kidney Cancer
ItalyStudy of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease
ItalyStudy of Avalotcagene Ontaparvovec for Patients Aged 12 and Older with Late-onset Ornithine Transcarbamylase Deficiency
ItalyStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyStudy of NMD670 tablets to improve muscle strength in adults with Type 3 spinal muscular atrophy who can walk
ItalyStudy on Chlorambucil and Rituximab for Patients with MALT Lymphoma
ItalyStudy of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma
ItalyStudy of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes
ItalyStudy on the Safety and Effectiveness of Venetoclax, Atezolizumab, and Obinutuzumab for Patients with Richter Syndrome from Chronic Lymphocytic Leukemia
ItalyStudy on the Effectiveness and Safety of Chloroprocaine Hydrochloride for Children Undergoing Flat Foot or Inguinal Hernia Surgery
ItalyStudy on De-escalated Induction Therapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab for Newly Diagnosed Primary CNS Lymphoma Patients
ItalyStudy of Atezolizumab and Drug Combination for Patients with Relapsed or Refractory Hodgkin's Lymphoma Eligible for Stem Cell Transplant
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma, colorectal cancer, and breast cancer treatments. Studies include evaluation of targeted therapies and immunotherapy approaches for various stages of disease.
Several trials are investigating combination therapies and maintenance treatments to improve patient outcomes.
Research centered on improving outcomes in kidney transplantation, with particular focus on preventing delayed graft function and optimizing post-transplant care.
Studies aim to enhance transplant success rates and reduce complications in organ recipients.
Investigations into treatments for various autoimmune disorders, including Crohn's Disease and pyoderma gangrenosum. Studies evaluate new biological therapies and combination treatments.
Focus on developing targeted treatments to improve disease control and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
